Angiogenesis and ophthalmic disease

被引：85

作者：

Adamis A.P. ^{[1
,2
,4
]}

Aiello L.P. ^{[3
]}

D'Amato R.A. ^{[1
,2
]}

机构：

[1] Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston

[2] Children's Hospital, Harvard Medical School, Boston

[3] Beetham Eye Institute, Joslin Diabetes Center, Harvard Medical School, Boston

[4] Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston

来源：

Angiogenesis | 1999年 / 3卷 / 1期

关键词：

Angiogenesis; Choroid; Cornea; Development; Eye; Iris; Neovascularization;

D O I：

10.1023/A:1009071601454

中图分类号：

学科分类号：

摘要：

Ocular angiogenesis is responsible for the majority of irreversible blindness in the developed world [1]. This debilitating complication affects all age groups and characterizes such diverse and widespread diseases as trachoma, retinopathy of prematurity, diabetic retinopathy, neovascular glaucoma and age-related macular degeneration. Although numerous relatively rare conditions also exhibit ocular angiogenesis, the aim of this review will be to briefly summarize our current knowledge regarding the clinical and laboratory findings of the most epidemiologically significant diseases. We will also describe current concepts regarding the pathogenesis of ocular angiogenesis. In this review the term 'neovascularization', which is more prevalent in the ophthalmic literature, will be used to describe the development of pathological new vessels and should be considered synonymous with 'angiogenesis'.

引用

页码：9 / 14

页数：5

共 69 条

[1] Lee, P., Wang, C.C., Adamis, A.P., Ocular neovascularization: An epidemiological review (1998) Surv Ophthalmol, 43, pp. 245-269
[2] Huang, A.J.W., Watson, B.D., Hernandez, E., Tseng, S.C.G., Induction of conjunctival transdifferentiation on vascularized corneas by photothrombotic occlusion of corneal neovascularization (1988) Ophthalmology, 95, pp. 228-235
[3] Huang, A.J.W., Watson, B.D., Hernandez, E., Tseng, S.C.G., Induction of conjunctival transdifferentiation on vascularized corneas by photothrombotic occlusion of corneal neovascularization (1988) Ophthalmology, 95, pp. 228-235
[4] Arentsen, J.J., Corneal neovascularization in contact lens wearers (1986) Int Ophthalmol Clin, 26, pp. 15-23
[5] Kruse, F.E., Chen, J.J.Y., Tsai, R.J.F., Tseng, S.C.G., Conjunctival transdifferentiation is due to the incomplete removal of limbal basal epithelium (1990) Invest Ophthalmol Vis Sci, 31, pp. 1903-1913
[6] Klintworth, G.K., (1990) Corneal Angiogenesis. A Comprehensive and Critical Review, 1st Edition, 26. , New York: Springer-Verlag
[7] Amano, S., Rohan, R., Kuroki, M., Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization (1998) Invest Ophthalmol Vis Sci, 39, pp. 18-22
[8] Cursifen, C., Hofman-Rummelt, C., Kuche, M.N.G.O.H., VEGF-immunoreactivity in human corneal buttons with neovascularization (1998) Invest Ophthalmol Vis Sci, 39, pp. S3418. , ARVO abstracts
[9] Michaelson, I.C., The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal disease (1948) Trans Ophthalmol Soc UK, 68, pp. 137-180
[10] Ashton, N., Retinal vascularization in health and disease (1957) Am J Ophthlamol, 44, pp. 7-24

← 1 2 3 4 5 6 7 →